New case study highlights how PatentVest helped Docana navigate a complex AI patent landscape through freedom-to-operate analysis, competitive intelligence, and strategic IP positioning. · The launch ...
Alnylam Pharmaceuticals (NasdaqGS:ALNY) reported new Phase 3 HELIOS-B analyses for vutrisiran in ATTR-CM. The data show reductions in all-cause mortality and cardiovascular events, including in ...
The A.I. model outperformed two doctors when presented with data from dozens of real E.R. patients. Harrison Keely via Wikimedia Commons under CC BY 4.0 Since the 1950s, scientists have been comparing ...
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced a new clinical case study ...
Erleada significantly reduces the risk of death by 51% in mCSPC patients compared to Nubeqa, without chemotherapy, over 24 months. The study used inverse probability of treatment weighting to ensure ...